Table 4.
Top canonical pathways | Ratio |
---|---|
Graft-versus-Host disease signaling | 5/51 (0.098) |
LXR/RXR activation | 7/139 (0.05) |
Granulocyte adhesion and diapedesis | 8/181 (0.044) |
FXR/RXR activation | 6/110 (0.055) |
Agranulocyte adhesion and diapedesis | 8/191 (0.042) |
Top biological functions | Molecules |
---|---|
Diseases and disorders | |
Cancer | 95 |
Inflammatory response | 53 |
Neurological disease | 46 |
Cardiovascular disease | 42 |
Organismal injury and abnormalities | 40 |
Molecular and cellular functions | |
Cellular growth and proliferation | 73 |
Cell to cell signaling/interaction | 54 |
Cellular movement | 53 |
Molecular transport | 52 |
Protein synthesis | 39 |
Physiological system development and function | |
Hematological system development/function | 60 |
Organismal development | 55 |
Tissue morphology | 47 |
Cardiovascular system development and function | 47 |
Immune cell trafficking | 39 |
IPA, ingenuity pathway analysis.